Cutaneous lymphoma of the tarsus in a cat - case study

Linfoma cutáneo tarsal en gato – estudio de caso

Lymphoma is the most common lymphoproliferative disorder in cats. Cutaneous lymphoma, however, is a rare form of extranodal lymphoma. Recently, several cutaneous lymphomas at the tarsal region have been reported in cats. As it differs clinically and histopathologically from the common cutaneous lymphoma, it was denominated cutaneous tarsal lymphoma. The present study describes the case of a 13-year-old male domestic longhair cat that presented with a subcutaneous mass, of 30-days evolution, at the tarsal region of the right pelvic limb. Histopathology analysis showed malignant neoplasia of round cells, morphologically suggestive of large cell lymphoma. Immunohistochemistry confirmed the diagnosis of B-immunoblastic lymphoma. Patient was treated with lomustine, and prednisolone with an overall survival time of 2.1 months. The aggressiveness of this feline lymphoma reinforces the need for further studies to understand better the disease progression and to establish improved therapeutic protocols that can increase survival time and improve quality of life of these patients.

1. Taylor SS, Googfelow MR, Browne WJ, Walding B, Murphy S. Tzannes S, et al. Feline extranodal lymphoma: response to chemotherapy and survival in 110 cats. J Small Anim Pract 2009; 50(11):584–592.
2. Komori S, Nakamura S, Takahashi K, Tagawa M. Use of lomustine to treat cutaneous nonepitheliotropic lymphoma in a cat. J Am Vet Med Assoc 2005; 226(2):237–239.
3. Fontaine J, Heimann M, Day MJ. Cutaneous epitheliotropic T-cell lymphoma in the cat: a review of the literature and five new cases. Vet Dermatol 2011; 22(5):454–461.
4. Burr HD, Keating JH, Clifford CA, Burgess KE. Cutaneous lymphoma of the tarsus in cats: 23 cases (2000-2012). J Am Vet Med Assoc. 2014; 244(12):1429-1434.
5. Valli VE, Jacobs R, Couto CG, Morrison W, Mccaw D, Cotter S, et al. The histologic classification of 602 cases of feline lymphoproliferative disease using the National Cancer Institute working formulation. J Vet Diagn Invest 2000; 12(4):295-306.
6. Bienzle D, Vernau W. The Diagnostic Assessment of Canine Lymphoma: Implications for Treatment. Clin Lab Med 2011; 31(1):21-39.
7. Vail DM. Feline lymphoma and leukemia. En: Withrow SJ, Vail DM. Editores. Withrow & MacEwen´s Small Animal Clinical Oncology. 5a ed.. St. Louis: Saunders Elsevier; 2013.
8. Gaidano G, Carbone A. MUM1: a step ahead toward the understanding of lymphoma histogenesis. Leukemia 2000; 14(4):563-566.
9. Feldman AL, Dogan A. Diagnostic uses of Pax5 immunohistochemistry. Adv Anat Pathol 2007; 14(5):323-334.
10. Jensen KC, Higgins J, Montgomery K, Kaygusuz G, Vanderijn M, Y. Natkunam. The utility of PAX5 immunohistochemistry in the diagnosis of undifferentiated malignant neoplasms. Mod Pathol 2007; 20(8):1-7.
11. Willemze R, Meijer CJ. Classification of cutaneous T-cell lymphoma: from Alibert to WHO-EORTC. J Cutan Pathol 2006; 33(1):18-26.
12. Grange F, Beylot-barry M, Courille P, Maubec E, Bagot M, Vergier B, et al. Primary cutaneous diffuse large B-cell lymphoma, leg type: Clinicopathologic features and prognostic analysis of 60 cases. Arch Dermatol 2007; 143(9):1144–1150.
13. Nyman HT, Kristen A, Skovgaard I, Mcevoy F. Characterization of normal and abnormal canine superficial lymph nodes using gray-scale B-mode, color flow mapping, power, and superficial Doppler ultrasonography: A multivariate study. Vet. Radiol. Ultrasound 2005; 46(5):404-410.
14. Grace S, Norsworthy G. Hemoplasmosis. En: Norsworthy GD. Editor. The feline patient. 4a ed. Iowa: Blackwell Publishing Ltd; 2011.
15. Biondo AW, Santos AP, Guimarães A, Vieira R, Vidotto O, Macieira DB, et al. A review of the occurrence of hemoplasmas (hemotrophic mycoplasmas) in Brazil. Rev Bras Parasitol 2009; 18(3):1-7.
16. Dutelle AL, Bulman-fleming J, Lewis C, Rosenberg M. Evaluation of lomustine as a rescue agent for cats with resistant lymphoma. J Fel Med Surgery 2012; 14(10):694-700.